SOCS3 and Alzheimer disease: These findings suggest that in AD, SOCS3 and PTP1B are initially reduced as compensatory adaptations to maintain leptin and cytokine signaling, but become upregulated at later stages, representing maladaptive responses that create a state of central leptin resistance and accelerate neurodegeneration.